Sculptra Dermik Laboratories - Treatment for Facial Lipoatrophy in HIV Patients
Sculptra is used for the restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.Posted: August 2004
Related Articles:
- FDA Approves Sculptra Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles - July 29, 2009
- Sculptra From Dermik Laboratories Receives Recommendation For Approval With Conditions From FDA Advisory Panel - March 26, 2004
- Aventis' Dermik Laboratories Announces FDA Acceptance of Filing For Sculptra to Treat Facial Lipoatrophy - February 6, 2004
Sculptra (injectable poly-L-lactic acid) FDA Approval History
